By Nigam Arora & Dr. Natasha Arora
ETFs have less risk than individual stocks. Several ETFs are now providing opportunities as they fall into buy zones.
Buy zones are very powerful. This powerful technique is used by billionaires and hedge funds. When a stock dips into the buy zone you buy it.
Semiconductors are the new oil for the economy. Semiconductors are now into almost everything. If you were a paying Arora Report subscriber, you were able to buy semiconductor ETF (SMH) as low as $96 Since then semiconductor ETF SMH as traded as high as $258.59. This represented a return of up to 169%.
No worries if you were not a paying subscriber. Semiconductor ETF SMH has fallen into the buy zone again.
With the help of buy zones, you could have bought internet ETF (FDN) which dipped into the buy zone trading as low as $105. Since then internet ETF FDN traded as high as $245.96 representing a gain of up to 133%.
If you missed buying internet ETF FDN, no worries, a new buy zones awaits you.
Marijuana
More and more states are legalizing marijuana. The marijuana business is booming. Marijuana ETF is in the buy zone.
Green Energy
Biden is pushing green energy. Solar and wind power is on the rise.
It is not only Tesla (TSLA) but General Motors (GM) and Ford (F ) are also pushing electric cars. Green energy ETF is in the buy zone.
Fintech
Pandemic has caused Fintech stocks to boom. The likes of PayPal (PYPL) and Square (SQ) are seeing increased use. Fintech is taking market share away from traditional banks. Fintech ETF is in the buy zone.
Biotech
Vaccines from Moderna (MRNA) and Pfizer (PFE) are saving the world from coronavirus. This is the golden age of biotech. Biotech ETF is in the buy zone.
ETFs To Reduce Risks
ETFs reduce your risks due to diversification. Our service ZYX Global Multi Asset Allocation Alert (ZYX Allocation) exclusively uses ETFs. This service is very popular among private investors, investment advisors and money managers.
Free Trial
You are cordially invited to take a 30 day free trial. Your credit card is not charged during the first 30 days. Easy cancel within 30 days and owe nothing if you do not want to continue. Most investors want to continue and become long time paying subscribers. Please click here to subscribe.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
